Alessandro Minisini

8PUBLICATIONS

39CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 26, 2026

Neoadjuvant Therapy and the Evolving Management of Resectable Advanced Melanoma.

|Jun 26, 2026

Adjuvant Approaches in Fully Resected Stage III and IV Cutaneous Melanoma: Where Are We Now?

|Jun 12, 2026

Adjuvant Therapy for High-Risk Stage II Cutaneous Melanoma: Insights and Future Directions.

|May 27, 2026

New Perspectives and Open Issues in the Adjuvant and Neoadjuvant Treatment of Melanoma.

|Sep 27, 2022

Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial.

Joan Albanell, José Manuel Pérez-García, Miguel Gil-Gil

|Aug 04, 2020

Immunotherapy for older patients with melanoma: From darkness to light?

Donatella Iacono, Maria Grazia Vitale, Debora Basile

Pageof 2

Frequent Collaborators

Paolo Fava

Jacopo Pigozzo

Gabriele Roccuzzo

Andrea Spagnoletti

Michele Del Vecchio

Luisa Piccin

Giacomo Pelizzari

Fabio Puglisi

Carolina Cimminiello

Marta Bonotto

Frequent Collaborators

Paolo Fava

Jacopo Pigozzo

Gabriele Roccuzzo

Andrea Spagnoletti